Is rosiglitazone associated with increased risk for cardiovascular events?

被引：0
作者：
Markolf Hanefeld
机构：
[1] M Hanefeld is Professor of Internal Medicine and Director of the Centre for Clinical Studies at the Technical University in Dresden,
[2] Germany.,undefined
来源：
Nature Clinical Practice Cardiovascular Medicine | 2007年 / 4卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：648 / 649
页数：1
相关论文
共 50 条
[31]   Long-term risk of cardiovascular events with rosiglitazone - A meta-analysis [J].
Singh, Sonal ;
Loke, Yoon K. ;
Furberg, Curt D. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (10) :1189-1195
[32]   ANGPTL2 is associated with an increased risk of cardiovascular events and death in diabetic patients [J].
Gellen, Barnabas ;
Thorin-Trescases, Nathalie ;
Sosner, Philippe ;
Gand, Elise ;
Saulnier, Pierre-Jean ;
Ragot, Stephanie ;
Fraty, Mathilde ;
Laugier, Stephanie ;
Ducrocq, Gregory ;
Montaigne, David ;
Llaty, Pierre ;
Rigalleau, Vincent ;
Zaoui, Philippe ;
Halimi, Jean-Michel ;
Roussel, Ronan ;
Thorin, Eric ;
Hadjadj, Samy .
DIABETOLOGIA, 2016, 59 (11) :2321-2330
[33]   Is Febuxostat Use Associated With Increased Risk of Cardiovascular Disease Events? The Answer Is Crystal Clear [J].
Charlton, Alexandra ;
MacMullan, Paul Anthony .
JOURNAL OF RHEUMATOLOGY, 2021, 48 (07) :965-966
[34]   The GPIIIA PIA2 polymorphism is associated with an increased risk of cardiovascular adverse events [J].
Galasso, Gennaro ;
Santulli, Gaetano ;
Piscione, Federico ;
De Rosa, Roberta ;
Trimarco, Valentina ;
Piccolo, Raffaele ;
Cassese, Salvatore ;
Iaccarino, Guido ;
Trimarco, Bruno ;
Chiariello, Massimo .
BMC CARDIOVASCULAR DISORDERS, 2010, 10
[35]   Stimulant treatment in healthy young people with ADHD is not associated with increased risk of cardiovascular events [J].
Elia, Josephine .
EVIDENCE-BASED MENTAL HEALTH, 2012, 15 (03) :56-56
[36]   Elevated serum neopterin is associated with increased risk of cardiovascular events in acute coronary syndromes [J].
Santoso, Anwar ;
Wardani, Sri ;
Surayana, Ketut .
INDONESIAN BIOMEDICAL JOURNAL, 2009, 1 (01) :61-67
[37]   Increased risk of cardiovascular events associated with the GPIIIA PlA2 polymorphism. [J].
De Rosa, R. ;
Galasso, G. ;
Piscione, F. ;
Santulli, G. ;
Iaccarino, G. ;
Piccolo, R. ;
Luciano, R. ;
Chiariello, M. .
CARDIOVASCULAR RESEARCH, 2010, 87 :S74-S75
[38]   Higher circulating omentin is associated with increased risk of primary cardiovascular events in individuals with diabetes [J].
Niersmann, Corinna ;
Carstensen-Kirberg, Maren ;
Maalmi, Haifa ;
Holleczek, Bernd ;
Roden, Michael ;
Brenner, Hermann ;
Herder, Christian ;
Schoettker, Ben .
DIABETOLOGIA, 2020, 63 (02) :410-418
[39]   Higher circulating omentin is associated with increased risk of primary cardiovascular events in individuals with diabetes [J].
Corinna Niersmann ;
Maren Carstensen-Kirberg ;
Haifa Maalmi ;
Bernd Holleczek ;
Michael Roden ;
Hermann Brenner ;
Christian Herder ;
Ben Schöttker .
Diabetologia, 2020, 63 :410-418
[40]   A mutation in the methylenetetrahydrofolate reductase gene is associated with increased risk of cardiovascular events in hypertensive patients [J].
Makris, TK ;
Hatzizacharias, AN ;
Krespi, PG ;
Anastasiadis, G ;
Stavroulakis, GA ;
Gialeraki, A ;
Chronakis, E ;
Chatzizacharias, NA ;
Kyriakidis, MK .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) :304A-304A
12345